Key result
Children with congenital heart disease show lower resilience scores versus healthy controls during COVID-19.
Why the study?
Resilience is a complex and rather unexplored topic in patients with congenital heart disease (CHD), leading the authors to assess and compare resilience in children with CHD with healthy controls during the COVID-19 pandemic.
Does having congenital heart disease reduce resilience in children compared to healthy controls during the COVID-19 pandemic?
Case-Control (n=248)
Does having congenital heart disease reduce resilience in children compared to healthy controls during the COVID-19 pandemic?
Absolute Event Rate: 59% vs 64.4%
p-value: p=<0.001
Children with congenital heart disease, particularly those with complex severity, exhibited significantly lower resilience compared to healthy peers during the COVID-19 pandemic.
Lower resilience in children with congenital heart disease during crises merits screening; hypothesis-generating for interventions.
OBJECTIVE: Resilience is a complex, yet rather unexplored topic in patients with congenital heart disease (CHD). The goal of this study was to assess and compare resilience in children with CHD with healthy controls during the COVID-19 pandemic. DESIGN AND PATIENTS: From June 2020 to June 2021, 124 children with various CHDs (14.6±2.1 years, 49 girls) and 124 matched healthy controls (14.8±2.0 years, 49 girls) completed the Resilience Scale-11 short version. RESULTS: Resilience was significantly reduced in children with CHD compared with healthy controls (CHD: 59.0±10.0 vs healthy controls: 64.4±6.5, p<0.001). That reduction was prominent in all CHD subgroups except those with left heart obstruction (aortic stenosis and coarctation of the aorta) and patients with transposition of the great arteries. Complex CHD had the lowest resilience of 57.6±8.4 (p<0.001) after adjusting for age and sex according to group differences. There was no difference between native CHD and CHD with open-heart surgery (native: 59.5±12.2 vs surgery: 58.8±9.3, p=0.758). CONCLUSIONS: Resilience was reduced in children and adolescents with CHD compared with healthy peers during the COVID-19 pandemic. Children with complex severity appeared to be particularly affected. These findings emphasise continued efforts to provide a holistic and multidisciplinary approach in medical aftercare of these patients and their families.
No takes yet. Share an insight, caveat, or question.
Köble et al. (2023) conducted a case-control in Congenital heart disease (n=248). Congenital heart disease vs. Healthy controls was evaluated on Resilience score (Resilience Scale-11 short version) (p=<0.001). Children with congenital heart disease had significantly lower resilience scores compared with matched healthy controls during the COVID-19 pandemic (59.0 vs 64.4, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: